Obstetric Cholestasis - GT 43 +TOG: Intrahepatic Cholestasis of Pregnancy Flashcards

1
Q

What % of pregnancies are affected by obstetric cholestasis?

A
  1. 7%

1. 2-1.5% of women of Indian/Pakistani descent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the perinatal risks of obstetric cholestasis?

A
  • Spontaneous/iatrogenic preterm birth
  • Increased risk CS
    fetal distress in labour
  • Fetal Death - likely small; risk above background not determined
  • Increase risk meconium passage proportional to bile acids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What % of women with obstetric cholestasis suffer with pruritis?

A

23%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the differential diagnoses of pruritis in pregnancy?

A

Eczema
Atopic eruption of pregnancy
Dermatographia artefacta (excoriations)
If rash - consider PEP/pemphigoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the risk factors for obstetric cholestasis?

A
Personal/family history
Multiple pregnancy
Hepatitis C
Gallstones
IVF
older women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What should be ruled out before diagnosing obstetric cholestasis?

A
  • Viral screen - Hep A, B, C, EBV, CMV
  • Liver autoimmune screen - Chronic active hepatitis and
    PBC (i.e. anti-smooth muscle, antimitochondrial
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What should be considered in atypical/early cases of obstetric cholestasis?

A

PET

Acute fatty liver of pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the recommended monitoring for women diagnosed with obstetric cholestasis?

A
  • LFTs weekly until delivery (consider coag screen if rapid elevation as atypical)
  • Defer LFTs until 10 days postnatal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the treatment for obstetric cholestasis?

A
  • Topical emolients
  • Antihistamines for sedation
  • Ursodeoxycholic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When should Vitamin K be used in treatment of obstetric cholestasis?

A

If PT prolonged needs 5-10mg Vitamin K daily, or woman has steatorrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the recurrence rate of obstetric cholestasis?

A

45-90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the contraceptive advice for women who have had obstetric cholestasis?

A

Best to avoid oestrogenic compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What environemntal factors are thought to influence risk of ICP (intrahepatic cholestasis of Pregnancy)

A

dietary selenium & vitamin D, seasonal cariation- more cases diagnosed in winter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

in what percentage of women does obs chole present after 30/40?

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what percentage of women suffer with jaundice associated with obs chole?

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the most sensitive and specific marker for diagnosing and monitoring obs chole?

A

bile acids

17
Q

if a woman who is 30/40 pregnant presents with itching suggestive of obstetric cholestasis, but bile acids and LFT’s are normal and itching continues, what suggestion has been made about how she should be managed?

A

if >24/40- weekly bile acids & LFTs until delivery

if <24/40- fortnightly bile acids &LFT’s

18
Q

if woman with obs chole presents with steatorrhoea, what blood test should be considered and why

A

coag screen- risk of malabsorption of fats and fat-soluble vitamins.

19
Q

what level of bile acid is associated with particular concern for adverse perinatal outcomes?

A

bile acid >40

20
Q

how does UDCA affect bile acids?

A

decreases level of bile acids in maternal and umbilical cord serum. Also causes qualitative changes in serum bile acid pool- consequent reduction of hydrophobicity of the pool

21
Q

what protective effects does UDCA have?

A

reduced risks preterm labour, reduced fetal distress during labour, reduced NNU admission

22
Q

what is a possible second line treatment for obstetric cholestasis

A

rifampicin- reduced pruritis and enhances bile acid secretion in primary biliary cirrhosis

23
Q

in what percentage of women treated with dual therapy- UDCA and rifampicin for obs chole, did the bile acid level reduce?

A

50% of women treated had reduced bile acid levels

24
Q

what are the future health risks for women with obstetric cholestasis?

A

increased incidence hepato-biliary disease (hepatitis, chronic hepatitis, hepatic fibrosis) in women with ICP

25
Q

what other diseases have been associated with women who have history of ICP

A

increased risk of liver cancer, cardiovascular disease, maternal diabetes
children of women with ICP are also at risk of metabolic disease later in life